A new resorbable magnesium scaffold (DREAMS 3G): 12-month vasomotion results from the BIOMAG-I first-in-human study.

IF 7.6 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Eurointervention Pub Date : 2024-09-02 DOI:10.4244/EIJ-D-24-00355

Michael Haude, Juan F Iglesias, Hector M Garcia-Garcia, Dimitrios Barlagiannis, Sophie Degrauwe, Gebremedhin Melaku, Solomon Beyene, Ron Waksman

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

新型可吸收镁支架（DREAMS 3G）：BIOMAG-I 首次人体研究的 12 个月血管运动结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Eurointervention CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

10.30

自引率

4.80%

发文量

380

审稿时长

3-8 weeks

期刊介绍： EuroIntervention Journal is an international, English language, peer-reviewed journal whose aim is to create a community of high quality research and education in the field of percutaneous and surgical cardiovascular interventions.

期刊最新文献

Early outcomes of the novel Myval THV series compared to SAPIEN THV series and Evolut THV series in individuals with severe aortic stenosis. TAVI with the ACURATE neo2 in severe bicuspid aortic valve stenosis: the Neo2 BAV Registry. Development and validation of the D-PACE scoring system to predict delayed high-grade conduction disturbances after transcatheter aortic valve implantation. Feasibility of redo-TAVI in the self-expanding ACURATE neo2 valve: a computed tomography study. Long-term survival after TAVI in low-flow, low-gradient aortic valve stenosis.